An observational study has uncovered a possible link between taking GLP-1s and increased risk of kidney, pancreas and gut ...

WEIGHT loss jabs protect against dozens of illnesses but raise the chances of 19 others, a study shows. Demand has rocketed ...

Ozempic, Wegovy and Mounjaro can reduce risk of heart disease, dementia, and much more, says groundbreaking US study ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and cardiovascular diseases, although experts warned against seeing ...

Weight-loss jabs could reduce your risk of drug abuse, seizures and pneumonia, as well as heart attacks and strokes, ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

One of the world’s largest studies of Ozempic, Mounjaro and other blockbuster diabetes and obesity drugs highlighted their ...

A Conservative former minister said he has lost more than five stone in weight after using weight-loss injections, as he ...

It may lower the risk of heart and blood disorders such as deep vein thrombosis and heart attack, as well as neurocognitive ...

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a study ...